Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions.

ABSTRACT:

Background

Chronic musculoskeletal pain (CMP) may lead to reduced physical function and is the most common cause of chronic non-cancer pain. Currently, the pharmacotherapeutic options against CMP are limited and frequently consist of pain management with non-steroidal anti-inflammatories, gabapentinoids, or opioids, which carry major adverse effects. Although the effectiveness of medical cannabis (MC) for CMP still lacks solid evidence, several patients suffering from it are exploring this therapeutic option with their physicians.

Objectives

Little is known about patients' perceptions of their MC treatment for CMP. We aimed to increase this knowledge, useful for healthcare professionals and patients considering this treatment, by conducting a scoping literature review, follo

SUBMITTER: Furrer D 

PROVIDER: S-EPMC8418709 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature